[A case of non-small cell lung cancer with hemodialysis which responded to docetaxel monotherapy].

Yumiko Abe, Kentaro Tanaka, Koichiro Matsumoto, Koichi Takayama, Hiroyuki Inoue, Miiru Izumi, Hiromasa Inoue, Yoichi Nakanishi

研究成果: ジャーナルへの寄稿記事

1 引用 (Scopus)

抄録

A 56-year-old man receiving hemodialysis treatment was hospitalized for examination of a mass in the right middle lobe. Chest computed tomography showed a right hilar mass shadow accompanied by pleural effusion. Non-small cell lung cancer (NSCLC) was diagnosed by cytological examination of the pleural effusion. No epidermal growth factor receptor (EGFR) mutation was found. He was treated with 6 courses of docetaxel as first-line chemotherapy. Docetaxel was administered on the same day as hemodialysis. Adverse events, including hematotoxicity, were managed safely and no delay in administration occurred. This chemotherapy resulted in a partial response. Because docetaxel is metabolized in the liver and does not affect renal function, it can be administered as a standard regimen. This suggests that docetaxel monotherapy is an efficient therapy for non-small cell lung cancer patients receiving hemodialysis.

元の言語英語
ページ(範囲)769-773
ページ数5
ジャーナルNihon Kokyūki Gakkai zasshi = the journal of the Japanese Respiratory Society
48
発行部数10
出版物ステータス出版済み - 1 1 2010

Fingerprint

docetaxel
Non-Small Cell Lung Carcinoma
Renal Dialysis
Pleural Effusion
Drug Therapy
Epidermal Growth Factor Receptor
Thorax
Tomography
Kidney
Mutation
Liver
Therapeutics

All Science Journal Classification (ASJC) codes

  • Medicine(all)

これを引用

[A case of non-small cell lung cancer with hemodialysis which responded to docetaxel monotherapy]. / Abe, Yumiko; Tanaka, Kentaro; Matsumoto, Koichiro; Takayama, Koichi; Inoue, Hiroyuki; Izumi, Miiru; Inoue, Hiromasa; Nakanishi, Yoichi.

:: Nihon Kokyūki Gakkai zasshi = the journal of the Japanese Respiratory Society, 巻 48, 番号 10, 01.01.2010, p. 769-773.

研究成果: ジャーナルへの寄稿記事

Abe, Yumiko ; Tanaka, Kentaro ; Matsumoto, Koichiro ; Takayama, Koichi ; Inoue, Hiroyuki ; Izumi, Miiru ; Inoue, Hiromasa ; Nakanishi, Yoichi. / [A case of non-small cell lung cancer with hemodialysis which responded to docetaxel monotherapy]. :: Nihon Kokyūki Gakkai zasshi = the journal of the Japanese Respiratory Society. 2010 ; 巻 48, 番号 10. pp. 769-773.
@article{24994366f9b54db6bd1172ad66a9f2a8,
title = "[A case of non-small cell lung cancer with hemodialysis which responded to docetaxel monotherapy].",
abstract = "A 56-year-old man receiving hemodialysis treatment was hospitalized for examination of a mass in the right middle lobe. Chest computed tomography showed a right hilar mass shadow accompanied by pleural effusion. Non-small cell lung cancer (NSCLC) was diagnosed by cytological examination of the pleural effusion. No epidermal growth factor receptor (EGFR) mutation was found. He was treated with 6 courses of docetaxel as first-line chemotherapy. Docetaxel was administered on the same day as hemodialysis. Adverse events, including hematotoxicity, were managed safely and no delay in administration occurred. This chemotherapy resulted in a partial response. Because docetaxel is metabolized in the liver and does not affect renal function, it can be administered as a standard regimen. This suggests that docetaxel monotherapy is an efficient therapy for non-small cell lung cancer patients receiving hemodialysis.",
author = "Yumiko Abe and Kentaro Tanaka and Koichiro Matsumoto and Koichi Takayama and Hiroyuki Inoue and Miiru Izumi and Hiromasa Inoue and Yoichi Nakanishi",
year = "2010",
month = "1",
day = "1",
language = "English",
volume = "48",
pages = "769--773",
journal = "Respiratory Investigation",
issn = "2212-5345",
publisher = "Elsevier BV",
number = "10",

}

TY - JOUR

T1 - [A case of non-small cell lung cancer with hemodialysis which responded to docetaxel monotherapy].

AU - Abe, Yumiko

AU - Tanaka, Kentaro

AU - Matsumoto, Koichiro

AU - Takayama, Koichi

AU - Inoue, Hiroyuki

AU - Izumi, Miiru

AU - Inoue, Hiromasa

AU - Nakanishi, Yoichi

PY - 2010/1/1

Y1 - 2010/1/1

N2 - A 56-year-old man receiving hemodialysis treatment was hospitalized for examination of a mass in the right middle lobe. Chest computed tomography showed a right hilar mass shadow accompanied by pleural effusion. Non-small cell lung cancer (NSCLC) was diagnosed by cytological examination of the pleural effusion. No epidermal growth factor receptor (EGFR) mutation was found. He was treated with 6 courses of docetaxel as first-line chemotherapy. Docetaxel was administered on the same day as hemodialysis. Adverse events, including hematotoxicity, were managed safely and no delay in administration occurred. This chemotherapy resulted in a partial response. Because docetaxel is metabolized in the liver and does not affect renal function, it can be administered as a standard regimen. This suggests that docetaxel monotherapy is an efficient therapy for non-small cell lung cancer patients receiving hemodialysis.

AB - A 56-year-old man receiving hemodialysis treatment was hospitalized for examination of a mass in the right middle lobe. Chest computed tomography showed a right hilar mass shadow accompanied by pleural effusion. Non-small cell lung cancer (NSCLC) was diagnosed by cytological examination of the pleural effusion. No epidermal growth factor receptor (EGFR) mutation was found. He was treated with 6 courses of docetaxel as first-line chemotherapy. Docetaxel was administered on the same day as hemodialysis. Adverse events, including hematotoxicity, were managed safely and no delay in administration occurred. This chemotherapy resulted in a partial response. Because docetaxel is metabolized in the liver and does not affect renal function, it can be administered as a standard regimen. This suggests that docetaxel monotherapy is an efficient therapy for non-small cell lung cancer patients receiving hemodialysis.

UR - http://www.scopus.com/inward/record.url?scp=79952110090&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79952110090&partnerID=8YFLogxK

M3 - Article

VL - 48

SP - 769

EP - 773

JO - Respiratory Investigation

JF - Respiratory Investigation

SN - 2212-5345

IS - 10

ER -